BMO Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $24
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
BMO Capital analyst Juan Sanabria maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $20 to $24.
BMO Capital analyst Juan Sanabria maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $20 to $24.